Becton DickinsonRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Becton Dickinson (BDX) reported revenue of $4.98B in Q2 2026, with Life Sciences its largest revenue segment at 51%.
Becton DickinsonBD sells medical essentials, connected care, biopharma systems, and interventional devices. It completed the spin of its former Biosciences and Diagnostic Solutions business into Waters on February 9, 2026.
Becton Dickinson (BDX) is a Health Care Equipment company. BD sells medical essentials, connected care, biopharma systems, and interventional devices. It completed the spin of its former Biosciences and Diagnostic Solutions business into Waters on February 9, 2026. It was founded in 1897, is headquartered in Franklin Lakes, New Jersey and employs about 72,000 people.
As of 2025-Q4, Becton Dickinson's revenue breaks down across Life Sciences (51%), Medical (49%). See the revenue-by-segment chart for the full mix.
Track Becton Dickinson's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated October 9, 2026.
Sterling groups Becton Dickinson in the Healthcare industry, alongside Abbott Laboratories (ABT), Baxter International (BAX), Boston Scientific (BSX), Edwards Lifesciences (EW), GE HealthCare (GEHC) and Idexx Laboratories (IDXX).
If you are researching Becton Dickinson, also look at Abbott Laboratories (ABT), Baxter International (BAX) and Boston Scientific (BSX). You can compare all of them side by side or browse the full Healthcare industry on Sterling.
Q3 2016-Q2 2026
Q3 2016-Q2 2026